{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:31:29Z","timestamp":1790353889151,"version":"4.1.0"},"reference-count":58,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"vor","delay-in-days":106,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.csbj.2019.04.010","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T20:15:55Z","timestamp":1555964155000},"page":"579-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Computational Simulations Identified Two Candidate Inhibitors of Cdk5\/p25 to Abrogate Tau-associated Neurological Disorders"],"prefix":"10.34133","volume":"17","author":[{"given":"Amir","family":"Zeb","sequence":"first","affiliation":[{"name":"Division of Life Science, Division of Applied Life Sciences (BK21 Plus), Research Institute of Natural Sciences (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Gyeongnam, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minky","family":"Son","sequence":"additional","affiliation":[{"name":"Division of Life Science, Division of Applied Life Sciences (BK21 Plus), Research Institute of Natural Sciences (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Gyeongnam, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghwa","family":"Yoon","sequence":"additional","affiliation":[{"name":"Division of Life Science, Division of Applied Life Sciences (BK21 Plus), Research Institute of Natural Sciences (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Gyeongnam, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Chemistry (BK21 Plus), Research Institute of Natural Science (RINS), Geyongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Gyeongnam, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Ju","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, Busan Paik Hospital, Inje University, Busan 47392, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Life Science, Division of Applied Life Sciences (BK21 Plus), Research Institute of Natural Sciences (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju 52828, Gyeongnam, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1075762"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.147553"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.091744"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/35096019"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1073\/pnas.96.20.11156","article-title":"Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation","volume":"96","author":"Sharma P.","year":"1999","unstructured":"Sharma P., Sharma M., Amin N.D., Albers R.W. and Pant H.C.: Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proc Natl Acad Sci U S A 1999; 96: 11156.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03233.x"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510405103"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2009.00536.x"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00627-5"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.02.024"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"13650","DOI":"10.1073\/pnas.2232515100","article-title":"Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease","volume":"100","author":"Smith P.D.","year":"2003","unstructured":"Smith P.D., Crocker S.J., Jackson-Lewis V., Jordan-Sciutto K.L., Hayley S., Mount M.P. et al: Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 2003; 100: 13650.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2217"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3237-08.2008"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0828-4"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3637-10.2010"},{"key":"e_1_3_4_17_2","first-page":"5124","article-title":"Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death","volume":"125","author":"Chang K.-H.","year":"2012","unstructured":"Chang K.-H., Vincent F. and Shah K.: Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death. J Cell Sci 2012; 125: 5124.","journal-title":"J Cell Sci"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.neuroscience.2015.01.054","article-title":"The inhibition of Cdk5 activity after hypoxia\/ischemia injury reduces infarct size and promotes functional recovery in neonatal rats","volume":"290","author":"Tan X.","year":"2015","unstructured":"Tan X., Chen Y., Li J., Li X., Miao Z., Xin N. et al: The inhibition of Cdk5 activity after hypoxia\/ischemia injury reduces infarct size and promotes functional recovery in neonatal rats. Neuroscience 2015; 290: 552.","journal-title":"Neuroscience"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20816"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0324"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1523\/JNEUROSCI.3593-12.2013","article-title":"Specific inhibition of p25\/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo","volume":"33","author":"Sundaram J.R.","year":"2013","unstructured":"Sundaram J.R., Poore C.P., Hazim N., Sulaimee B., Pareek T., Asad A.B.M.A. et al: Specific inhibition of p25\/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo. J Neurosci 2013; 33: 334.","journal-title":"J Neurosci"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"40013","DOI":"10.1038\/srep40013","article-title":"TFP5 peptide, derived from Cdk5-activating cofactor p35, provides neuroprotection in early-stage of adult ischemic stroke","volume":"7","author":"Ji Y.-B.","year":"2017","unstructured":"Ji Y.-B., Zhuang P.-P., Ji Z., Wu Y.-M., Gu Y., Gao X.-Y. et al: TFP5 peptide, derived from Cdk5-activating cofactor p35, provides neuroprotection in early-stage of adult ischemic stroke. Sci Rep 2017; 7: 40013.","journal-title":"Sci Rep"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.bmc.2010.01.042","article-title":"Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosing","volume":"18","author":"Brasca M.G.","year":"2010","unstructured":"Brasca M.G., Albanese C., Alzani R., Amici R., Avanzi N., Ballinari D. et al: Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosing. Bioorg Med Chem 2010; 18: 1844.","journal-title":"Bioorg Med Chem"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0621-17.2017"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.10.015"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/cdd.2015.103","article-title":"Phosphorylation of CHIP at Ser20 by Cdk5 promotes tAIF-mediated neuronal death","volume":"23","author":"Kim C.","year":"2015","unstructured":"Kim C., Yun N., Lee J., Youdim M., Ju C., Kim W.-K. et al: Phosphorylation of CHIP at Ser20 by Cdk5 promotes tAIF-mediated neuronal death. Cell Death Differ 2015; 23: 333.","journal-title":"Cell Death Differ"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm049323m"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063030","article-title":"A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitors","volume":"8","author":"Arooj M.","year":"2013","unstructured":"Arooj M., Sakkiah S., Kim S., Arulalapperumal V. and Lee K.W.: A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitors. PLoS One 2013; 8: e63030.","journal-title":"PLoS One"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/ci00020a020","article-title":"Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships","volume":"34","author":"Rogers D.","year":"1994","unstructured":"Rogers D. and Hopfinger A.J.: Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. J Chem Inf Comput Sci 1994; 34: 854.","journal-title":"J Chem Inf Comput Sci"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"13740","DOI":"10.3390\/molecules171213740","article-title":"Generation of the first structure-based pharmacophore model containing a selective \u201czinc binding group\u201d feature to identify potential glyoxalase-1 inhibitors","volume":"17","author":"Al-Balas Q.","year":"2012","unstructured":"Al-Balas Q., Hassan M., Al-Oudat B., Alzoubi H., Mhaidat N. and Almaaytah A.: Generation of the first structure-based pharmacophore model containing a selective \u201czinc binding group\u201d feature to identify potential glyoxalase-1 inhibitors. Molecules 2012; 17: 13740.","journal-title":"Molecules"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2174\/1568026023392940","article-title":"History and evolution of the pharmacophore concept in computer-aided drug design","volume":"2","author":"Guner O.","year":"2002","unstructured":"Guner O.: History and evolution of the pharmacophore concept in computer-aided drug design. Curr Top Med Chem 2002; 2: 1321.","journal-title":"Curr Top Med Chem"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"14921","DOI":"10.1038\/s41598-018-33354-6","article-title":"Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay","volume":"8","author":"Jang C.","year":"2018","unstructured":"Jang C., Yadav D.K., Subedi L., Venkatesan R., Venkanna A., Afzal S. et al: Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay. Sci Rep 2018; 8: 14921.","journal-title":"Sci Rep"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-015-0607-6"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2012.01339.x"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1038\/s41598-017-11302-0","article-title":"New compounds identified through in silico approaches reduce the \u03b1-synuclein expression by inhibiting prolyl oligopeptidase in vitro","volume":"7","author":"Kumar R.","year":"2017","unstructured":"Kumar R., Bavi R., Gi Jo M., Arulalapperumal V., Baek A., Rampogu S. et al: New compounds identified through in silico approaches reduce the \u03b1-synuclein expression by inhibiting prolyl oligopeptidase in vitro. Sci Rep 2017; 7: 10827.","journal-title":"Sci Rep"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acschemneuro.8b00405","article-title":"Structure-based drug designing recommends HDAC6 inhibitors to attenuate microtubule-associated Tau-pathogenesis","volume":"10","author":"Zeb A.","year":"2019","unstructured":"Zeb A., Park C., Rampogu S., Son M., Lee G. and Lee K.W.: Structure-based drug designing recommends HDAC6 inhibitors to attenuate microtubule-associated Tau-pathogenesis. ACS Chem Neurosci 2019; 10: 1326. n.d..","journal-title":"ACS Chem Neurosci"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.compbiolchem.2017.01.004","article-title":"Pharmacoinformatics study of Piperolactam A from Piper betle root as new lead for non steroidal anti fertility drug development","volume":"67","author":"Amin S.A.","year":"2017","unstructured":"Amin S.A., Bhattacharya P., Basak S., Gayen S., Nandy A. and Saha A.: Pharmacoinformatics study of Piperolactam A from Piper betle root as new lead for non steroidal anti fertility drug development. Comput Biol Chem 2017; 67: 213.","journal-title":"Comput Biol Chem"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2017.1288659"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk M.L.","year":"2003","unstructured":"Verdonk M.L., Cole J.C., Hartshorn M.J., Murray C.W. and Taylor R.D.: Improved protein-ligand docking using GOLD. Proteins Struct Funct Genet 2003; 52: 609.","journal-title":"Proteins Struct Funct Genet"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci500081m"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt055"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21816"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.328693"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja9039373"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci500020m"},{"key":"e_1_3_4_47_2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jcc.21683","article-title":"Crystal molecular dynamics simulations to speed up MM\/PB(GB)SA evaluation of binding free energies of di-mannose deoxy analogs with P51G-m4-Cyanovirin-N","volume":"32","author":"Vorontsov I.I.","year":"2011","unstructured":"Vorontsov I.I. and Miyashita O.: Crystal molecular dynamics simulations to speed up MM\/PB(GB)SA evaluation of binding free energies of di-mannose deoxy analogs with P51G-m4-Cyanovirin-N. J Comput Chem 2011; 32: 1043.","journal-title":"J Comput Chem"},{"key":"e_1_3_4_48_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12551-013-0130-2","article-title":"Receptor-ligand molecular docking","volume":"6","author":"Guedes I.A.","year":"2014","unstructured":"Guedes I.A., De Magalh\u00e3es C.S. and Dardenne L.E.: Receptor-ligand molecular docking. Biophys Rev 2014; 6: 75.","journal-title":"Biophys Rev"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7401160"},{"key":"e_1_3_4_50_2","unstructured":"SciFinder - Sign In n.d.https:\/\/scifinder.cas.org\/scifinder\/login"},{"key":"e_1_3_4_51_2","unstructured":"Reaxys n.d.https:\/\/www.reaxys.com\/#\/login"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/45159"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00259-9"},{"key":"e_1_3_4_54_2","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1073\/pnas.040577797","article-title":"Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5","volume":"97","author":"Ahlijanian M.K.","year":"1999","unstructured":"Ahlijanian M.K., Barrezueta N.X., Williams R.D., Jakowski A., Kowsz K.P., Mccarthy S. et al: Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci U S A 1999; 97: 2910.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_4_55_2","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23112824","article-title":"Novel transforming growth factor-beta receptor 1 antagonists through a pharmacophore-based virtual screening approach","volume":"23","author":"Jiang J.","year":"2018","unstructured":"Jiang J., Zhou H., Jiang Q., Sun L. and Deng P.: Novel transforming growth factor-beta receptor 1 antagonists through a pharmacophore-based virtual screening approach. Molecules 2018; 23.","journal-title":"Molecules"},{"key":"e_1_3_4_56_2","first-page":"811","article-title":"Defining Cdk5 ligand chemical space with small molecule inhibitors of Tau phosphorylation","volume":"12","author":"Ahn J.S.","year":"2005","unstructured":"Ahn J.S., Radhakrishnan M.L., Mapelli M., Choi S., Tidor B., Cuny G.D. et al: Defining Cdk5 ligand chemical space with small molecule inhibitors of Tau phosphorylation. Cell Chem Biol 2005; 12: 811.","journal-title":"Cell Chem Biol"},{"key":"e_1_3_4_57_2","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1016\/j.bmcl.2012.07.068","article-title":"Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)\/p25 inhibitors","volume":"22","author":"Malmstr\u00f6m J.","year":"2012","unstructured":"Malmstr\u00f6m J., Viklund J., Slivo C., Costa A., Maudet M., Sandelin C. et al: Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)\/p25 inhibitors. Bioorg Med Chem Lett 2012; 22: 5919.","journal-title":"Bioorg Med Chem Lett"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(02)00004-2"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120563"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037019300583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037019300583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2019.04.010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:06:15Z","timestamp":1778267175000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2019.04.010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":58,"alternative-id":["10.1016\/j.csbj.2019.04.010"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2019.04.010","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational Simulations Identified Two Candidate Inhibitors of Cdk5\/p25 to Abrogate Tau-associated Neurological Disorders","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2019.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}